companydata.dkSPECIFIC PHARMA A/S: Financial statements 2026
CVR: 33161395
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2026. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. That is a decrease of 28.1% compared with the year before. The profit margin was 9.6%. Equity amounted to DKK 98,645,000. The solvency ratio was 85.6%. The company had 33 employees in the financial year.
- Revenue
- 157,797,000 kr.
- Gross Profit
- 38,182,000 kr.
- Profit/Loss
- 15,192,000 kr.
- Equity
- 98,645,000 kr.
- Total Assets
- 115,179,000 kr.
- Employees
- 33
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | 157.8 mio. | 38.2 mio. | 15.2 mio. | 98.6 mio. | 33 |
| 2025 | 219.3 mio. | 57.3 mio. | 29.2 mio. | 111.2 mio. | 28 |
| 2024 | 211 mio. | 48.5 mio. | 25.6 mio. | 106.2 mio. | 25 |
| 2023 | 177.6 mio. | 34.7 mio. | 9.9 mio. | 89.6 mio. | 25 |
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
Keep an eye on SPECIFIC PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2026
Contact info changed: new email: [email protected] (June 23, 2026).
Contact info changed: new email: [email protected] (June 18, 2026).
Contact info changed: new email: [email protected] (June 17, 2026).
As of June 17, 2026, Kasper Casparij Yde has joined the board of directors of SPECIFIC PHARMA A/S.
As of June 17, 2026, Pia Rask Stewart has left the board of directors of SPECIFIC PHARMA A/S.
Contact info changed: new email: [email protected] (March 31, 2026).
As of March 23, 2026, Kristine Sakstrup Haag has joined the board of directors of SPECIFIC PHARMA A/S.
As of March 23, 2026, Henrik Kaastrup has joined the board of directors of SPECIFIC PHARMA A/S.
As of March 22, 2026, Kristine Sakstrup Haag has left the board of directors of SPECIFIC PHARMA A/S.
As of March 22, 2026, Henrik Kaastrup has left the board of directors of SPECIFIC PHARMA A/S.
About SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.